Non-invasive prognostic factors in chronic heart failure. One-year survival of 300 patients with a diagnosis of chronic heart failure due to ischemic heart disease or dilated cardiomyopathy

International Journal of Cardiology

Volumn 56, Issue 3, 1996, Pages 283-288

  Spinar, J ^a   Vitovec J ^a   Spac, J ^a   Blaha, M ^a   Spinarova, L ^a   Toman, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

congestive heart failure; ejection fraction; exercise; functional class; lung changes; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030601705     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02740-4     Document Type: Article

References (29)

1. [1] Shocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-306.
2. [2] Ho KL, Pinsky JL, Kannel WB et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: s.6A-13A.
3. [3] The Consensus Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandinavian enalapril survival study (consensus). N Engl J Med 1987; 316: 1329-1435.
4. [4] Conn JN, Johnson G, Zieshe S et al. Comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chrome heart failure. N Engl J Med 1991; 325: 303-310.
5. [5] The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
6. [6] The SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced-left ventricular ejection fraction. N Engl J Med 1992; 327: 685-691
7. [7] The AIRE study investigators: effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-828.
8. [8] Ho KL, Anderson KM, Kannel WB et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993; 88: 107-115.
9. [9] Scrutinio D, Lagioia R, Ricci A et al. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. Eur Heart J 1994; 15: 1089-1095.
10. [10] The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-751.
11. [11] Meszaros WT. Lung changes in left heart failure. Circulation 1973; 47: 869-872.
12. [12] Spinar J, Vítovec J, Blaha M et al. Radiologic changes in congestive heart failure. Cort Vasa 1992; 34: 88-99.
13. [13] Gradman A, Deedwania P, Cody R et al. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989; 14: 564-570.
14. [14] Madsen BK, Hansen JF, Stokholm KH et al. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994; 15: 303-310.
15. [15] Parameshwar J, Keegan J, Sparrow J et al. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992; 123: 421-426.
16. [16] Cohn JN, Archibald DG, Francis GS et al. Veterans administration cooperative study on vasodilatator therapy of heart failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation 1987; 75: IV49-IV54.
17. [17] Cohn JN, Johnson GR. Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. The V-HEFT VA Cooperative Studies Group. Circulation 1993: 87: VI15-VI16.
18. [18] McNamara RF, Carleen E, Moss AJ. The multicentre post-infarction research group. Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. Am J Cardiol 1988; 62: 192-196.
19. [19] Potter JF, Elahi D, Tobin JD, et al. Effect of aging on the cardiothoracic ratio of men. J Am Geriatr Soc 1982; 30: 404-409.
20. [20] Glover DR, Litter W. Factors influencing survival and mode death in severe chronic ischemic cardiac failure. Br Heart J 1987; 57: 125-132.
21. [21] Saxon LA, Stewenson WG, Middlekauf HR et al. Predicting death from progressive heart failure secondary to ischemic or idiopatic dilated cardiomyopathy. Am J Cardiol 1993; 72: 62-65.
22. [22] Braunwald E. Heart Disease, 3rd edn. W.B. Saunders, Boston, MA, 1988; 1900 pp.
23. [23] Rollag A, Mangsschau A, Jonsbu J et al. Do X-ray determined cardiac volume and signs of congestive heart failure provide additional information after myocardial infarction if the left ventricular fraction is known? J Int Med 1989; 225: 267-272.
24. [24] Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe heart failure. Circulation 1986; 73: 257-267.
25. [25] Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopatic dilated or ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634-638.
26. [26] White HD. Theft ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
27. [27] ESC working Group on Exercise Physiology, Physiopathology and Electrocardiography. Guidelines for cardiac exercise testing. Eur Heart J 1993; 14: 969-988.
28. [28] Cohn JN, Ziesche SM, Archibald DG, and the V.A. Cooperative Study Group. Quantitative exercise tolerance as a predictor of mortality in congestive heart failure. Circulation 1986; 74: II 447.
29. [29] Cohn JN. Prognostic factors in heart failure: poverty amidst a wealth of variables. J Am Coll Cardiol 1989; 14: 571-572.